Enlivex Therapeutics LtdGewinn- und Verlustrechnung
| Preis (2026-07-23) | 52W Hoch | 52W Tief |
| 4.36 USD | 31,5 USD | 4,25 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 300 USD | 1 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 16.832.015 | 0,63 | 3,96 |
Kennzahl in 1000 USD | 2020-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% |